LENZ Therapeutics (LENZ) Shares Outstanding (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Shares Outstanding data on file, last reported at $31.4 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $31.4 million, up 13.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.4 million (up 13.87% YoY), and the FY2025 annual result was $31.3 million, up 13.9% from the prior year.
• Shares Outstanding steadied at $31.4 million in Q1 2026 per LENZ's latest filing, from $31.3 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $58.2 million in Q2 2022 and troughed at $207137.0 in Q3 2022.
• A 5-year average of $25.6 million and a median of $27.5 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding sank 96.64% in 2022, then jumped 1299.38% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $1.9 million in 2022, then advanced by 1.15% to $2.0 million in 2023, then surged by 1297.33% to $27.5 million in 2024, then advanced by 13.9% to $31.3 million in 2025, then grew by 0.03% to $31.4 million in 2026.
• Business Quant data shows LENZ's Shares Outstanding at $31.4 million in Q1 2026, $31.3 million in Q4 2025, and $28.6 million in Q3 2025.